Valencell

Valencell transforms the science of wearable biometrics to enable impactful health outcomes. Through innovative R&D and validated technologies, we develop breakthroughs and collaborate with wearables, hearables, and medical device companies around the world to deliver amazing results.

With more than 85 granted patents and 100+ patents pending around the world, Valencell’s technology continuously and accurately measures real-time biometric and physiological data that powers meaningful consumer and patient insights.

Founded: Founded in 2006 and headquartered in Raleigh, North Carolina

Investors: Halma, Sonion, TDF Ventures, GII TECH, and WSJ Joshua Fund

Leadership
Kent Novak, Chairman, CEO
Steven LeBoeuf, Ph.D., Founder & President
Michael Aumer, Ph.D., VP of R&D
Kristine O'Shea, VP of Finance
Mark Felice, VP of Business Development and Licensing
Ryan Kraudel, VP of Marketing
Chris Eschbach, Ph.D., HFS, CSCS, Exercise Physiologist

4601 Six Forks Road
Suite 103
Raleigh, NC 27609

919-747-3668 / [email protected] / www.valencell.com